Aytu BioPharma, Inc.
NASDAQ: AYTU0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Joshua R. Disbrow
- Employees
- 102
- Headquarters
- Englewood, United States
- IPO year
- 2008
- Market cap
- $17.7M
- Website
- https://aytubio.com
Loading AYTU…
Loading profile data…Frequently asked questions about AYTU
What does Aytu BioPharma, Inc. (AYTU) do?
Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international markets. Its commercialized portfolio includes several treatments for Attention Deficit Hyperactivity Disorder (ADHD): Adzenys XR-ODT, prescribed fo...
Where does AYTU trade?
Aytu BioPharma, Inc. (AYTU) trades on the NASDAQ Capital Market.
What sector is AYTU in?
Aytu BioPharma, Inc. (AYTU) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aytu BioPharma, Inc.?
Joshua R. Disbrow is the chief executive officer of Aytu BioPharma, Inc. (AYTU).
Where is Aytu BioPharma, Inc. headquartered?
Aytu BioPharma, Inc. is headquartered in United States.
Does AYTU pay a dividend?
Aytu BioPharma, Inc. (AYTU) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AYTU go public?
Aytu BioPharma, Inc. (AYTU) completed its initial public offering in 2008.